Standard

Hereditary breast cancer and ovarian cancer : Clinical course and treatment. / Semiglazov, V. V.; Protasova, A. E.; Kalikeev, G. K.

в: Opuholi Zenskoj Reproduktivnoj Sistemy, Том 16, № 4, 2020, стр. 54-65.

Результаты исследований: Научные публикации в периодических изданиях › статья › Рецензирование

Harvard

Semiglazov, VV, Protasova, AE & Kalikeev, GK 2020, 'Hereditary breast cancer and ovarian cancer: Clinical course and treatment', Opuholi Zenskoj Reproduktivnoj Sistemy, Том. 16, № 4, стр. 54-65. https://doi.org/10.17650/1994-4098-2020-16-4-54-65

APA

Semiglazov, V. V., Protasova, A. E., & Kalikeev, G. K. (2020). Hereditary breast cancer and ovarian cancer: Clinical course and treatment. Opuholi Zenskoj Reproduktivnoj Sistemy, 16(4), 54-65. https://doi.org/10.17650/1994-4098-2020-16-4-54-65

Vancouver

Semiglazov VV, Protasova AE, Kalikeev GK. Hereditary breast cancer and ovarian cancer: Clinical course and treatment. Opuholi Zenskoj Reproduktivnoj Sistemy. 2020;16(4):54-65. https://doi.org/10.17650/1994-4098-2020-16-4-54-65

Author

Semiglazov, V. V. ; Protasova, A. E. ; Kalikeev, G. K. / Hereditary breast cancer and ovarian cancer : Clinical course and treatment. в: Opuholi Zenskoj Reproduktivnoj Sistemy. 2020 ; Том 16, № 4. стр. 54-65.

BibTeX

@article{fb206b3394634af28a0cbffb59cd2601,
title = "Hereditary breast cancer and ovarian cancer: Clinical course and treatment",
abstract = "This article analyzes current problems associated with surgical and systemic treatment for hereditary breast and ovarian cancers (including those associated with BRCA1/2 gene mutations). We discuss the issues related to clinical course of multiple primary tumors and their sensitivity to cytostatic and targeted therapy.",
keywords = "BRCA1, BRCA2, Breast cancer, CHEK2, Multiple primary tumors, Ovarian cancer, PARP inhibitors",
author = "Semiglazov, {V. V.} and Protasova, {A. E.} and Kalikeev, {G. K.}",
note = "Publisher Copyright: {\textcopyright} 2020 ABC-press Publishing House. All right reserved.",
year = "2020",
doi = "10.17650/1994-4098-2020-16-4-54-65",
language = "English",
volume = "16",
pages = "54--65",
journal = "Opuholi Zenskoj Reproduktivnoj Sistemy",
issn = "1994-4098",
publisher = "Издательский дом {"}АБВ-пресс{"} ",
number = "4",

}

RIS

TY - JOUR

T1 - Hereditary breast cancer and ovarian cancer

T2 - Clinical course and treatment

AU - Semiglazov, V. V.

AU - Protasova, A. E.

AU - Kalikeev, G. K.

N1 - Publisher Copyright: © 2020 ABC-press Publishing House. All right reserved.

PY - 2020

Y1 - 2020

N2 - This article analyzes current problems associated with surgical and systemic treatment for hereditary breast and ovarian cancers (including those associated with BRCA1/2 gene mutations). We discuss the issues related to clinical course of multiple primary tumors and their sensitivity to cytostatic and targeted therapy.

AB - This article analyzes current problems associated with surgical and systemic treatment for hereditary breast and ovarian cancers (including those associated with BRCA1/2 gene mutations). We discuss the issues related to clinical course of multiple primary tumors and their sensitivity to cytostatic and targeted therapy.

KW - BRCA1

KW - BRCA2

KW - Breast cancer

KW - CHEK2

KW - Multiple primary tumors

KW - Ovarian cancer

KW - PARP inhibitors

UR - http://www.scopus.com/inward/record.url?scp=85108941045&partnerID=8YFLogxK

U2 - 10.17650/1994-4098-2020-16-4-54-65

DO - 10.17650/1994-4098-2020-16-4-54-65

M3 - Article

AN - SCOPUS:85108941045

VL - 16

SP - 54

EP - 65

JO - Opuholi Zenskoj Reproduktivnoj Sistemy

JF - Opuholi Zenskoj Reproduktivnoj Sistemy

SN - 1994-4098

IS - 4

ER -

ID: 88554169